Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis

Bronchiectasis Clinical Trial

Official title:

Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05838144
• Other study ID #: PT-IMG-02/2023-505
• Status: Recruiting
• Phase: N/A
• Start date: August 1, 2023
• Est. completion date: October 20, 2023

Study information

• Verified date: July 2023
• Source: South Valley University
• Contact: Shymaa Y Abo zaid
• Phone: 01010941685
• Email: shaymaayoussef397[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

1. Acapella group. Will use Acapella device for 3 times per day for 15 minutes for 7 days beside medications and routine chest physical therapy program .

2. Only routine physical therapy program group ( control group). Will only take medications and routine chest physical therapy program.

Description:

1. Acapella group.Will use Acapella device for 3 times per day for 15 minutes for 7 days beside medications and routine chest physical therapy program.

2. Only routine physical therapy program group( control group). Will only take medications and routine chest physical therapy program Spirometer measures such as forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1) will be measured for every patient before and after the end of 7 days.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: October 20, 2023
• Est. primary completion date: September 30, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 40 Years to 55 Years

Eligibility

Inclusion Criteria:

1. bronchiectasis patients.

2. Age range between 40 to 55 years old of both gender.

3. Cooperative patients.

Exclusion Criteria:

1. Patients with severe cardiac disorders.

2. Un controlled hypertensive patients.

3. Un controlled diabetic patients.

Related Conditions & MeSH terms

• Bronchiectasis

Intervention

Device:
• Acapella device
Group A. Will use Acapella device.

Other:
• Only routine chest physical therapy program
Group B. Will take medications and perform routine chest physical therapy program.

Locations

Country	Name	City	State
Egypt	Shymaa yussuf abo zaid	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
South Valley University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Spirometry measures	FVC, FEV1	7 days